Premium Access: Available NOW Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
Opexa Therapeutics develops and commercializes cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes. The Company is focused on autologous cellular therapy applications of its proprietary T-cell and stem cell therapies. The Company's lead product, Tovaxin, a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license for adult multipotent stem cells derived from mononuclear cells of peripheral blood. The technology allows large quantities of monocyte derived stem cells to be produced efficiently for use in autologous therapy, thus circumventing the threat of rejection. The Company is in preclinical development for diabetes mellitus. For more information, visit the Opexa Therapeutics website at www.opexatherapeutics.com.
Last Trade
0.2800
Volume
11,299
Change
+0.02
Shares
n.a.
Change %
+7.53%
Market Cap.
3.19M
Today's High
0.3180
52 Week High
n.a.
Today's Low
0.2800
52 Week Low
n.a.
Bid
0.22 x n.a.
EPS
-1.56
Ask
199,999.99 x n.a.
P/E Ratio
-0.16667
Open
0.3
Div. Per Share
n.a.
Previous Close
0.26
Exchange
NMS
User Comments
0 Bulls
0 Bears
Be the first to comment on Opexa Therapeutics, Inc (NASDAQ: OPXA)
Teradata Corporation is the world's largest company solely focused on raising intelligence through data warehousing, consulting services and enterprise analytics. Teradata is in more than 60 countries…
Starwood Hotels & Resorts Worldwide, Inc., together with its subsidiaries, operates as a hotel and leisure company worldwide. It primarily operates luxury and upscale full service hotels, retreats, and…
GeneThera, Inc., a development stage biotechnology company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms. The company…
Vein Clinics of America, a wholly owned subsidiary of IntegraMed America, Inc.,
Horizon Air, an Alaska Air Group, Inc. company,
Ingen Technologies, Inc.
Featured Company:
